lobbying_filings_raw: 0719d77a-e5e9-4af0-8f3b-d1f800bf7ca4
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0719d77a-e5e9-4af0-8f3b-d1f800bf7ca4 | Q1 | 401105649 | MICHAEL YAKI CONSULTING | 205825 | ANTIMICROBIALS WORKING GROUPS | 2021 | first_quarter | 2021-04-06T10:21:08.227000-04:00 | 30000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/0719d77a-e5e9-4af0-8f3b-d1f800bf7ca4/", "filing_uuid": "0719d77a-e5e9-4af0-8f3b-d1f800bf7ca4", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2021, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/0719d77a-e5e9-4af0-8f3b-d1f800bf7ca4/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Michael J Yaki", "dt_posted": "2021-04-06T10:21:08.227000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "Po Box 387, The Sea Ranch, CA 95497", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "The Sea Ranch", "registrant_state": "CA", "registrant_zip": "95497", "registrant": {"id": 401105649, "url": "https://lda.senate.gov/api/v1/registrants/401105649/", "house_registrant_id": null, "name": "MICHAEL YAKI CONSULTING", "description": "Consulting", "address_1": "Po Box 387, The Sea Ranch, CA 95497", "address_2": null, "address_3": null, "address_4": null, "city": "The Sea Ranch", "state": "CA", "state_display": "California", "zip": "95497", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MICHAEL YAKI", "contact_telephone": "+1 415-601-4008", "dt_updated": "2023-09-11T13:25:20.039032-04:00"}, "client": {"id": 205825, "url": "https://lda.senate.gov/api/v1/clients/205825/", "client_id": 12, "name": "ANTIMICROBIALS WORKING GROUPS", "general_description": "Antimicrobial research and development", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2020-05-06"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R. 1319 and S.Con.Res 5, inclusion of provisions of HR 4100 (116th Congress)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 87825, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": "JOHN", "last_name": "YAKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "HR 1319 and S.Con.Res 5, inclusion of provisions of HR 4100 (116th Congress)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 87825, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": "JOHN", "last_name": "YAKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 1319 and S.Con.Res. 5, inclusion of provisions of HR 4100 (116th Congress)", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 87825, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": "JOHN", "last_name": "YAKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | CA | US | DC | DC | US | US | Antimicrobial research and development | 0 | 0 |